Skip to main content
Erschienen in: Trials 1/2021

Open Access 01.12.2021 | Letter

A Phase I/II Clinical Trial to evaluate the efficacy of baricitinib to prevent respiratory insufficiency progression in onco-hematological patients affected with COVID19: A structured summary of a study protocol for a randomised controlled trial

verfasst von: G. Moreno-González, A. Mussetti, A. Albasanz-Puig, I. Salvador, A. Sureda, C. Gudiol, R. Salazar, M. Marin, M. Garcia, V. Navarro, I. de la Haba Vaca, E. Coma, G. Sanz-Linares, X. Dura, S. Fontanals, G. Serrano, C. Cruz, R. Mañez

Erschienen in: Trials | Ausgabe 1/2021

download
DOWNLOAD
print
DRUCKEN
Metadaten
Titel
A Phase I/II Clinical Trial to evaluate the efficacy of baricitinib to prevent respiratory insufficiency progression in onco-hematological patients affected with COVID19: A structured summary of a study protocol for a randomised controlled trial
verfasst von
G. Moreno-González
A. Mussetti
A. Albasanz-Puig
I. Salvador
A. Sureda
C. Gudiol
R. Salazar
M. Marin
M. Garcia
V. Navarro
I. de la Haba Vaca
E. Coma
G. Sanz-Linares
X. Dura
S. Fontanals
G. Serrano
C. Cruz
R. Mañez
Publikationsdatum
01.12.2021
Verlag
BioMed Central
Erschienen in
Trials / Ausgabe 1/2021
Elektronische ISSN: 1745-6215
DOI
https://doi.org/10.1186/s13063-021-05072-4

Weitere Artikel der Ausgabe 1/2021

Trials 1/2021 Zur Ausgabe